Stock Markets Torn Between Optimism Over Vaccines And Discouragement Over Macro Data

AstraZeneca announced today that its vaccine, developed together with the University of Oxford, shows 90% efficacy in one of its trials by administering "half a dose, followed by a full dose with an interval of at least one month ".
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.